Here's What A Doctor Thinks Are The Biggest Vaccination Challenges
Will consumers one day have a choice of which coronavirus vaccine they receive? Will the market for vaccines be overly complicated once other players join Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) in earning Emergency Use Authorization or formal approvals? Dr. Bruce Gellin of the Sabin Vaccine Institute joined Olivia Zitkus and Corinne Cardina of Fool.com's Healthcare and Cannabis Bureau on a Dec. 18 episode of Fool Live to talk about the challenges of vaccination logistics and the importance of information technology.
Source Fool.com
